News Your BP Patients Can Use: U.S. FDA Approves Dupilumab to Treat Adults With BP
JDNPPA co-editor Margaret Bobonich, DNP, FNP-C, DCNP, FAANP, Founder of the Center for Dermatology NP PA, discusses the significance of the U.S. Food and Drug Administration (FDA) approval of dupilumab (Dupixent, Sanofi & Regeneron) for bullous pemphigoid (BP) and what it will mean for BP patients.